KIF18A-IN-14
KIF18A-IN-14 (Compound Example 81) is a KIF18A inhibitor. KIF18A-IN-14 is available in two forms, EX81-A and its enantiomer EX81-B. EX81-A and EX81-B inhibit OVCAR-3 cells viability with IC50s of 0-0.01 μM and 0.01-0.1 μM, respectively. KIF18A-IN-14 can be used in tumor (e.g. colon, breast, lung) studies[1].
Product Specifications
CAS Number
[3051552-75-8]
UNSPSC
12352005
Target
Kinesin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kif18a-in-14.html
Smiles
O=C1NC2=CC=CC(N3CCOC(C3)COCC4(C(F)(F)F)CCN(CC4)C5=CC(NS(=O)(CCO)=O)=CC=C15)=N2
Molecular Formula
C26H32F3N5O6S
Molecular Weight
599.62
References & Citations
[1]Ding, et al. Inhibitors of kif18a and uses thereof. WO2024153217.WIPO, 2024-01-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Pantothenate Kinase 3, NT (Pantothenic Acid Kinase 3, PANK3, hPanK3, DKFZp686O22247, FLJ12899, MGC16863) (MaxLight 650)
Pantothenate Kinase 3, NT (Pantothenic Acid Kinase 3, PANK3, hPanK3, DKFZp686O22247, FLJ12899, MGC16863) (MaxLight 650)